AMPHOTERICIN B LIPOSOME

AMPHOTERICIN B LIPOSOME was reported 2364 times

AMPHOTERICIN B LIPOSOME is most commonly taken among patients reporting these side effects:

# Side effect Count Frequency
0 MYOCARDITIS MYCOTIC 2 0.0833
1 NECROTISING FASCIITIS FUNGAL 2 0.0800
2 CROSS INFECTION 1 0.0769
3 MENINGITIS ASPERGILLUS 1 0.0714
4 CHIASMA SYNDROME 1 0.0625
5 EPIDIDYMAL DISORDER 1 0.0476
6 HYPERTENSIVE HYDROCEPHALUS 1 0.0435
7 GEOTRICHUM INFECTION 9 0.0427
8 KWASHIORKOR 1 0.0417
9 GASTROINTESTINAL WALL THINNING 2 0.0400
10 ACUTE ALLOGRAFT NEPHROPATHY 1 0.0370
11 MICROSPORUM INFECTION 1 0.0312
12 ACUTE MYELOID LEUKAEMIA (IN REMISSION) 1 0.0294
13 PENICILLIUM INFECTION 5 0.0278
14 FLAP NECROSIS 1 0.0270
15 ENDOCARDITIS CANDIDA 2 0.0263
16 BENIGN SOFT TISSUE NEOPLASM 1 0.0263
17 SEPTAL PANNICULITIS 2 0.0250
18 MUCOCUTANEOUS LEISHMANIASIS 3 0.0246
19 BASAL GANGLIA HAEMATOMA 1 0.0238
20 VISCERAL LEISHMANIASIS 17 0.0235
21 LIVER GRAFT LOSS 1 0.0233
22 BRONCHITIS HAEMOPHILUS 1 0.0227
23 HISTIOCYTOSIS 3 0.0226
24 TRICHOSPORON INFECTION 9 0.0222
25 FUSARIUM INFECTION 15 0.0214
26 ADJUSTED CALCIUM INCREASED 1 0.0189
27 LIVER TRANSPLANT FAILURE 1 0.0182
28 OSTEOMYELITIS FUNGAL 3 0.0180
29 ELECTROCARDIOGRAM T WAVE BIPHASIC 1 0.0179
30 INFECTION PROTOZOAL 1 0.0175
31 LEISHMANIASIS 5 0.0172
32 ABSCESS FUNGAL 3 0.0171
33 MUCORMYCOSIS 44 0.0169
34 INFECTIVE AORTITIS 1 0.0167
35 ELECTROCARDIOGRAM U WAVE PRESENT 1 0.0161
36 ABDOMINAL WALL OEDEMA 1 0.0159
37 CNS VENTRICULITIS 5 0.0153
38 MEDIASTINAL SHIFT 1 0.0149
39 CEREBRAL ASPERGILLOSIS 9 0.0146
40 CORYNEBACTERIUM TEST POSITIVE 1 0.0141
41 INFERIOR VENA CAVA SYNDROME 1 0.0141
42 ARTHRITIS FUNGAL 1 0.0139
43 DISSEMINATED TRICHOSPORONOSIS 1 0.0139
44 BLAST CELL COUNT DECREASED 1 0.0137
45 HEPATOSPLENIC CANDIDIASIS 2 0.0136
46 DIAPHRAGMATIC INJURY 1 0.0135
47 IDIOPATHIC PNEUMONIA SYNDROME 4 0.0134
48 FUNGAL ABSCESS CENTRAL NERVOUS SYSTEM 1 0.0132
49 CENTRAL NERVOUS SYSTEM FUNGAL INFECTION 3 0.0129
50 SINUSITIS ASPERGILLUS 2 0.0127
51 HEPATIC SIDEROSIS 1 0.0125
52 CHRONIC GRANULOMATOUS DISEASE 1 0.0122
53 BURKHOLDERIA INFECTION 1 0.0120
54 HEPATIC ARTERY OCCLUSION 1 0.0118
55 CAROTID ARTERY ANEURYSM 4 0.0117
56 SCEDOSPORIUM INFECTION 8 0.0113
57 ENCEPHALITIS FUNGAL 1 0.0111
58 DISSEMINATED CRYPTOCOCCOSIS 8 0.0106
59 CONGENITAL PNEUMONIA 1 0.0105
60 PHAEOHYPHOMYCOSIS 5 0.0104
61 ACINETOBACTER TEST POSITIVE 2 0.0103
62 MENINGITIS CRYPTOCOCCAL 18 0.0103
63 IMAGING PROCEDURE ABNORMAL 1 0.0100
64 FUNGAL RHINITIS 1 0.0093
65 FUNGAEMIA 14 0.0089
66 SYSTEMIC MYCOSIS 10 0.0086
67 AMOEBIASIS 2 0.0085
68 HUMAN METAPNEUMOVIRUS TEST POSITIVE 1 0.0085
69 BRACHIOCEPHALIC VEIN THROMBOSIS 1 0.0081
70 SPLENIC LESION 3 0.0081
71 INFECTIVE ANEURYSM 4 0.0081
72 NEPHROGENIC DIABETES INSIPIDUS 9 0.0078
73 DISSOCIATIVE AMNESIA 1 0.0077
74 CONJUNCTIVAL ULCER 1 0.0072
75 ATYPICAL MYCOBACTERIAL PNEUMONIA 1 0.0072
76 ALKALOSIS HYPOCHLORAEMIC 1 0.0071
77 CRANIAL NERVE PALSIES MULTIPLE 1 0.0071
78 IIIRD NERVE DISORDER 1 0.0070
79 ENGRAFT FAILURE 2 0.0070
80 PERIOSTITIS 3 0.0069
81 ABSCESS STERILE 1 0.0068
82 CRYPTOCOCCOSIS 11 0.0067
83 FUNGAL ENDOCARDITIS 2 0.0066
84 EYE ABSCESS 2 0.0066
85 DACRYOCYSTITIS 1 0.0065
86 ASPERGILLUS INFECTION 41 0.0062
87 BLASTOMYCOSIS 3 0.0062
88 GASTROINTESTINAL MUCORMYCOSIS 1 0.0060
89 IMMUNE RECONSTITUTION INFLAMMATORY SYNDROME 29 0.0058
90 DELAYED GRAFT FUNCTION 4 0.0056
91 ENCAPSULATING PERITONEAL SCLEROSIS 1 0.0056
92 DIAPHRAGMATIC RUPTURE 1 0.0056
93 RESPIRATORY GAS EXCHANGE DISORDER 2 0.0054
94 HEPATIC INFARCTION 2 0.0053
95 BRONCHOPULMONARY ASPERGILLOSIS 40 0.0052
96 PULMONARY MYCOSIS 4 0.0051
97 DISSEMINATED MUCORMYCOSIS 2 0.0051
98 ENGRAFTMENT SYNDROME 3 0.0051
99 CELLULITIS GANGRENOUS 1 0.0051
100 PRODUCT CONTAMINATION MICROBIAL 6 0.0050
101 ANTIBIOTIC LEVEL ABOVE THERAPEUTIC 2 0.0049
102 MITOCHONDRIAL TOXICITY 4 0.0049
103 MUSCLE ABSCESS 3 0.0048
104 KERATITIS FUNGAL 1 0.0048
105 DYSBACTERIOSIS 1 0.0047
106 BLOOD STEM CELL TRANSPLANT FAILURE 1 0.0047
107 LYMPH GLAND INFECTION 2 0.0044
108 CEREBRAL CYST 3 0.0044
109 HERPES ZOSTER CUTANEOUS DISSEMINATED 1 0.0043
110 DISSEMINATED ASPERGILLOSIS 2 0.0042
111 BIOPSY SKIN ABNORMAL 1 0.0042
112 INFECTIVE SPONDYLITIS 1 0.0041
113 CARDIAC VALVE VEGETATION 2 0.0041
114 SYSTEMIC CANDIDA 10 0.0040
115 CUTANEOUS LEISHMANIASIS 1 0.0040
116 CAVERNOUS SINUS THROMBOSIS 1 0.0039
117 LEUKAEMIC INFILTRATION EXTRAMEDULLARY 1 0.0039
118 CORNEAL THINNING 1 0.0039
119 GINGIVAL EROSION 1 0.0039
120 METAPNEUMOVIRUS INFECTION 3 0.0038
121 RESPIRATORY TRACT INFECTION FUNGAL 2 0.0038
122 CSF PRESSURE INCREASED 1 0.0038
123 CHOLANGITIS INFECTIVE 1 0.0038
124 PNEUMONIA LEGIONELLA 6 0.0037
125 SINUSITIS FUNGAL 3 0.0037
126 SEPTIC EMBOLUS 3 0.0036
127 GENITOURINARY TRACT INFECTION 1 0.0035
128 CEREBRAL FUNGAL INFECTION 1 0.0035
129 CELLULITIS ORBITAL 2 0.0034
130 CATHETER SITE CELLULITIS 1 0.0034
131 HEPATIC ARTERY THROMBOSIS 1 0.0034
132 GRAFT COMPLICATION 2 0.0034
133 FIBRIN DEGRADATION PRODUCTS INCREASED 1 0.0034
134 CATHETER SITE HAEMATOMA 1 0.0034
135 INTESTINAL INFARCTION 3 0.0033
136 ERYTHROPOIESIS ABNORMAL 1 0.0033
137 ASPERGILLUS TEST POSITIVE 1 0.0032
138 URINARY TRACT INFECTION ENTEROCOCCAL 3 0.0032
139 BRAIN ABSCESS 8 0.0032
140 HISTOPLASMOSIS DISSEMINATED 5 0.0031
141 ASPERGILLOMA 1 0.0031
142 CELLULITIS STAPHYLOCOCCAL 2 0.0031
143 LUNG LOBECTOMY 1 0.0030
144 GASTRIC VARICES HAEMORRHAGE 1 0.0030
145 GASTROENTERITIS BACTERIAL 1 0.0030
146 BLOOD LACTATE DEHYDROGENASE DECREASED 1 0.0030
147 ELECTROCARDIOGRAM T WAVE AMPLITUDE DECREASED 1 0.0029
148 FUNGAL TEST POSITIVE 1 0.0028
149 MICROSPORIDIA INFECTION 1 0.0028
150 GRANULOMATOUS LIVER DISEASE 2 0.0028
151 RENAL TUBULAR DISORDER 8 0.0028
152 GRAFT VERSUS HOST DISEASE IN GASTROINTESTINAL TRACT 6 0.0028
153 CYTOMEGALOVIRUS ENTERITIS 1 0.0028
154 PROTEUS INFECTION 2 0.0028
155 COMPLICATIONS OF TRANSPLANTED LIVER 1 0.0028
156 DYSPLASTIC NAEVUS 1 0.0028
157 CHRONIC GRAFT VERSUS HOST DISEASE IN LIVER 1 0.0027
158 PNEUMONIA KLEBSIELLA 5 0.0027
159 MIXED ANXIETY AND DEPRESSIVE DISORDER 1 0.0027
160 ENTEROBACTER SEPSIS 1 0.0027
161 CHOROIDITIS 1 0.0027
162 ACUTE PHASE REACTION 1 0.0026
163 MULTIPLE ORGAN DYSFUNCTION SYNDROME 74 0.0026
164 ARTERIAL RUPTURE 2 0.0026
165 CYTOMEGALOVIRUS ENTEROCOLITIS 2 0.0026
166 BONE MARROW INFILTRATION 1 0.0026
167 MICROANGIOPATHIC HAEMOLYTIC ANAEMIA 2 0.0025
168 IIIRD NERVE PARALYSIS 2 0.0025
169 SEPSIS NEONATAL 2 0.0025
170 FUNGAL SEPSIS 2 0.0024
171 GASTROINTESTINAL CANDIDIASIS 1 0.0024
172 HISTIOCYTOSIS HAEMATOPHAGIC 7 0.0024
173 ACUTE MYELOID LEUKAEMIA RECURRENT 5 0.0023
174 GRAFT VERSUS HOST DISEASE IN SKIN 5 0.0023
175 CHRONIC MYELOID LEUKAEMIA TRANSFORMATION 1 0.0022
176 GASTRIC FISTULA 1 0.0022
177 MENINGOENCEPHALITIS HERPETIC 1 0.0022
178 CANDIDA SEPSIS 2 0.0022
179 MUCOSAL EROSION 2 0.0022
180 ACUTE GRAFT VERSUS HOST DISEASE 10 0.0022
181 BILIARY SEPSIS 1 0.0022
182 BACTERIAL SEPSIS 7 0.0021
183 CEREBRAL HYPOPERFUSION 1 0.0021
184 POLYOMAVIRUS-ASSOCIATED NEPHROPATHY 5 0.0021
185 IMMUNOSUPPRESSANT DRUG LEVEL INCREASED 7 0.0021
186 GRAFT VERSUS HOST DISEASE IN LUNG 1 0.0021
187 RENAL INFARCT 3 0.0021
188 HYPERGAMMAGLOBULINAEMIA 1 0.0021
189 HYPOCOAGULABLE STATE 2 0.0021
190 CEREBRAL ARTERY STENOSIS 1 0.0020
191 ANGIOCENTRIC LYMPHOMA 1 0.0020
192 ELECTROCARDIOGRAM QT INTERVAL ABNORMAL 1 0.0020
193 LOWER RESPIRATORY TRACT INFECTION BACTERIAL 1 0.0020
194 PNEUMONIA PSEUDOMONAL 3 0.0020
195 ACQUIRED IMMUNODEFICIENCY SYNDROME 1 0.0019
196 HYPHAEMA 1 0.0019
197 BLAST CELL COUNT INCREASED 2 0.0019
198 BRAIN MIDLINE SHIFT 1 0.0019
199 HUMAN POLYOMAVIRUS INFECTION 1 0.0019
200 ENTEROCOCCAL INFECTION 9 0.0019
201 TOXOPLASMOSIS 2 0.0019
202 STREPTOCOCCAL BACTERAEMIA 2 0.0018
203 HYPOKALAEMIA 84 0.0018
204 LEUKAEMIA RECURRENT 3 0.0018
205 VITH NERVE PARALYSIS 2 0.0018
206 INFECTION REACTIVATION 2 0.0017
207 PUPILS UNEQUAL 2 0.0017
208 METHAEMOGLOBINAEMIA 4 0.0017
209 MEDIASTINITIS 1 0.0017
210 PSEUDOMONAL SEPSIS 3 0.0017
211 RECTAL ULCER 2 0.0017
212 INCISION SITE PAIN 2 0.0017
213 EPSTEIN-BARR VIRUS ASSOCIATED LYMPHOMA 1 0.0017
214 PNEUMONIA INFLUENZAL 2 0.0017
215 PNEUMOCYSTIS JIROVECII INFECTION 2 0.0017
216 IMMUNOSUPPRESSANT DRUG LEVEL DECREASED 2 0.0017
217 LONG QT SYNDROME 4 0.0017
218 GAMMA-GLUTAMYLTRANSFERASE ABNORMAL 1 0.0017
219 HEPATORENAL FAILURE 1 0.0017
220 FAT NECROSIS 1 0.0016
221 RENAL TUBULAR INJURY 2 0.0016
222 FEBRILE CONVULSION 2 0.0016
223 LARGE INTESTINE INFECTION 2 0.0016
224 OTOTOXICITY 3 0.0016
225 BLOOD MAGNESIUM DECREASED 14 0.0016
226 INTRACRANIAL PRESSURE INCREASED 9 0.0016
227 WHITE MATTER LESION 2 0.0016
228 ABDOMINAL COMPARTMENT SYNDROME 1 0.0016
229 ANAL INFLAMMATION 1 0.0016
230 HEPATOSPLENOMEGALY 4 0.0016
231 ACUTE LYMPHOCYTIC LEUKAEMIA RECURRENT 4 0.0015
232 ENTEROCOCCUS TEST POSITIVE 1 0.0015
233 CYTOMEGALOVIRUS CHORIORETINITIS 3 0.0015
234 GRAFT VERSUS HOST DISEASE 11 0.0015
235 NEPHROPATHY TOXIC 17 0.0015
236 ILEAL PERFORATION 1 0.0015
237 EMPYEMA 3 0.0015
238 CYTOMEGALOVIRUS INFECTION 25 0.0015
239 BK VIRUS INFECTION 5 0.0015
240 ABSCESS NECK 1 0.0015
241 MARROW HYPERPLASIA 1 0.0015
242 CUTANEOUS SYMPTOM 1 0.0015
243 COMPUTERISED TOMOGRAM THORAX ABNORMAL 1 0.0015
244 CAPILLARY LEAK SYNDROME 3 0.0014
245 NEUTROPENIC COLITIS 3 0.0014
246 DRUG LEVEL BELOW THERAPEUTIC 8 0.0014
247 ARACHNOIDITIS 1 0.0014
248 RASH MORBILLIFORM 4 0.0014
249 HYPOMAGNESAEMIA 20 0.0014
250 LUNG CONSOLIDATION 4 0.0014
251 H1N1 INFLUENZA 2 0.0014
252 CANDIDA INFECTION 24 0.0014
253 INFECTION IN AN IMMUNOCOMPROMISED HOST 1 0.0014
254 ESCHERICHIA SEPSIS 4 0.0014
255 ESCHAR 1 0.0014
256 LIP EROSION 1 0.0014
257 DIFFERENTIATION SYNDROME 1 0.0014
258 B-CELL TYPE ACUTE LEUKAEMIA 1 0.0014
259 NOSOCOMIAL INFECTION 3 0.0014
260 FUNGAL INFECTION 45 0.0013
261 APRAXIA 2 0.0013
262 PATHOGEN RESISTANCE 12 0.0013
263 INFECTIOUS PLEURAL EFFUSION 2 0.0013
264 DRUG RESISTANCE 33 0.0013
265 CRITICAL ILLNESS 1 0.0013
266 ESCHERICHIA BACTERAEMIA 3 0.0013
267 ENDOCARDITIS BACTERIAL 1 0.0013
268 PNEUMONIA FUNGAL 5 0.0013
269 INHIBITORY DRUG INTERACTION 2 0.0013
270 TOXIC EPIDERMAL NECROLYSIS 19 0.0012
271 ENTEROCOCCAL SEPSIS 1 0.0012
272 KETONURIA 1 0.0012
273 HYPOPYON 1 0.0012
274 HAEMOPHAGOCYTIC LYMPHOHISTIOCYTOSIS 9 0.0012
275 VENOOCCLUSIVE DISEASE 3 0.0012
276 SEPTIC SHOCK 52 0.0012
277 AMAUROSIS 1 0.0012
278 BONE MARROW FAILURE 24 0.0012
279 ELECTRIC SHOCK 1 0.0012
280 MYCOBACTERIAL INFECTION 2 0.0012
281 ACUTE SINUSITIS 2 0.0012
282 TORSADE DE POINTES 9 0.0011
283 SPLENIC INFARCTION 2 0.0011
284 AXONAL NEUROPATHY 1 0.0011
285 CEREBELLAR ATROPHY 1 0.0011
286 INCORRECT PRODUCT FORMULATION ADMINISTERED 1 0.0011
287 HISTOPLASMOSIS 2 0.0011
288 RENAL TUBULAR NECROSIS 11 0.0011
289 TRANSPLANT DYSFUNCTION 2 0.0011
290 MYCOBACTERIUM AVIUM COMPLEX INFECTION 3 0.0011
291 BLOOD ALKALINE PHOSPHATASE ABNORMAL 1 0.0011
292 HEART TRANSPLANT 1 0.0011
293 SOFT TISSUE INFECTION 2 0.0011
294 COLOUR BLINDNESS 1 0.0011
295 MACULE 3 0.0011
296 CHRONIC GRAFT VERSUS HOST DISEASE IN SKIN 1 0.0011
297 NECROSIS 6 0.0011
298 PANCYTOPENIA 60 0.0011
299 BLOOD UREA ABNORMAL 1 0.0011
300 HUMAN HERPESVIRUS 6 INFECTION 2 0.0011
301 DELAYED RECOVERY FROM ANAESTHESIA 1 0.0011
302 HYPOPROTEINAEMIA 2 0.0011
303 SYSTEMIC INFLAMMATORY RESPONSE SYNDROME 4 0.0010
304 CEREBELLAR ATAXIA 1 0.0010
305 KIDNEY TRANSPLANT REJECTION 5 0.0010
306 ELECTROLYTE IMBALANCE 12 0.0010
307 PNEUMONIA CYTOMEGALOVIRAL 2 0.0010
308 STRIDOR 3 0.0010
309 VENOOCCLUSIVE LIVER DISEASE 5 0.0010
310 GENE MUTATION 2 0.0010
311 HYPOFIBRINOGENAEMIA 1 0.0010
312 ENDOPHTHALMITIS 6 0.0010
313 KLEBSIELLA INFECTION 5 0.0010
314 GENOTYPE DRUG RESISTANCE TEST POSITIVE 1 0.0010
315 VENOUS THROMBOSIS LIMB 2 0.0010
316 MULTIPLE-DRUG RESISTANCE 3 0.0010
317 BONE MARROW OEDEMA 1 0.0010
318 VARICELLA ZOSTER VIRUS INFECTION 2 0.0010
319 BLOOD POTASSIUM DECREASED 29 0.0010
320 GASTROINTESTINAL VIRAL INFECTION 1 0.0010
321 LUNG ABSCESS 2 0.0010
322 ALANINE AMINOTRANSFERASE ABNORMAL 2 0.0009
323 HALLUCINATION, VISUAL 20 0.0009
324 HYPERPHOSPHATAEMIA 2 0.0009
325 HAEMORRHAGIC DISORDER 1 0.0009
326 ACINETOBACTER INFECTION 1 0.0009
327 CEREBELLAR SYNDROME 2 0.0009
328 CYTOMEGALOVIRUS INFECTION REACTIVATION 4 0.0009
329 TREATMENT FAILURE 75 0.0009
330 PARESIS 2 0.0009
331 KLEBSIELLA SEPSIS 1 0.0009
332 CHRONIC GASTRITIS 2 0.0009
333 COMPLICATIONS OF TRANSPLANTED KIDNEY 2 0.0009
334 LICHENOID KERATOSIS 2 0.0009
335 ARTERIAL HAEMORRHAGE 1 0.0009
336 CHEMICAL BURN 1 0.0009
337 GRANULOMA 3 0.0009
338 BILIRUBIN CONJUGATED INCREASED 2 0.0009
339 TYPE I HYPERSENSITIVITY 3 0.0009
340 INTRA-ABDOMINAL HAEMORRHAGE 2 0.0008
341 COCCIDIOIDOMYCOSIS 1 0.0008
342 ACUTE MYELOID LEUKAEMIA 13 0.0008
343 CHRONIC GRAFT VERSUS HOST DISEASE 3 0.0008
344 HEPATITIS CHOLESTATIC 5 0.0008
345 VENTRICULAR FIBRILLATION 9 0.0008
346 STAPHYLOCOCCAL SEPSIS 4 0.0008
347 TACHYPNOEA 11 0.0008
348 STEM CELL TRANSPLANT 2 0.0008
349 HYPERAMMONAEMIA 4 0.0008
350 DRUG INEFFECTIVE 1049 0.0008
351 URINARY TRACT INFECTION BACTERIAL 2 0.0008
352 PHOTOPSIA 5 0.0008
353 LIVER FUNCTION TEST ABNORMAL 23 0.0008
354 BAND SENSATION 1 0.0008
355 MALLORY-WEISS SYNDROME 1 0.0008
356 LEFT ATRIAL DILATATION 1 0.0008
357 SKIN NECROSIS 4 0.0008
358 ASPERGILLOSIS 1 0.0008
359 LUNG OPACITY 2 0.0008
360 LYMPHOCYTE PERCENTAGE DECREASED 1 0.0007
361 FUNGAL SKIN INFECTION 3 0.0007
362 GASTRIC PERFORATION 2 0.0007
363 CARBON DIOXIDE INCREASED 1 0.0007
364 EFFUSION 1 0.0007
365 ANAPHYLACTOID REACTION 3 0.0007
366 INFUSION SITE RASH 1 0.0007
367 CENTRAL NERVOUS SYSTEM LYMPHOMA 1 0.0007
368 ENCEPHALITIS 5 0.0007
369 BLOOD CREATININE INCREASED 47 0.0007
370 PSYCHOMOTOR RETARDATION 2 0.0007
371 ATYPICAL MYCOBACTERIAL INFECTION 1 0.0007
372 LOW DENSITY LIPOPROTEIN DECREASED 1 0.0007
373 ACUTE LYMPHOCYTIC LEUKAEMIA 2 0.0007
374 FEBRILE BONE MARROW APLASIA 3 0.0007
375 PURULENT DISCHARGE 3 0.0007
376 PARAPLEGIA 2 0.0007
377 DRUG INEFFECTIVE FOR UNAPPROVED INDICATION 38 0.0007
378 RENAL IMPAIRMENT 58 0.0007
379 FLUID OVERLOAD 10 0.0007
380 GASTROINTESTINAL NECROSIS 2 0.0007
381 GROWTH RETARDATION 2 0.0007
382 PANCREATITIS ACUTE 15 0.0007
383 PAPILLOEDEMA 3 0.0007
384 HAEMORRHAGIC TRANSFORMATION STROKE 1 0.0007
385 GENITAL HERPES 1 0.0007
386 PORTAL HYPERTENSION 2 0.0006
387 BRAIN DEATH 2 0.0006
388 RESPIRATORY FAILURE 47 0.0006
389 PULMONARY HAEMORRHAGE 5 0.0006
390 MEGACOLON 1 0.0006
391 TRANSAMINASES INCREASED 14 0.0006
392 ACUTE KIDNEY INJURY 96 0.0006
393 STUPOR 2 0.0006
394 ANTIPHOSPHOLIPID SYNDROME 1 0.0006
395 ACUTE RESPIRATORY DISTRESS SYNDROME 11 0.0006
396 PRODUCT PREPARATION ISSUE 4 0.0006
397 IGA NEPHROPATHY 1 0.0006
398 FEBRILE NEUTROPENIA 40 0.0006
399 OLIGOHYDRAMNIOS 2 0.0006
400 DERMATITIS EXFOLIATIVE 3 0.0006
401 MENINGITIS 4 0.0006
402 CEREBRAL HAEMATOMA 2 0.0006
403 WOUND DEHISCENCE 2 0.0006
404 DRUG LEVEL DECREASED 6 0.0006
405 SUBARACHNOID HAEMORRHAGE 6 0.0006
406 INCORRECT ROUTE OF PRODUCT ADMINISTRATION 10 0.0006
407 PSEUDOMONAS INFECTION 5 0.0006
408 HYPERAMMONAEMIC ENCEPHALOPATHY 1 0.0006
409 DERMATITIS EXFOLIATIVE GENERALISED 2 0.0006
410 PAPULE 4 0.0006
411 DRUG ERUPTION 10 0.0006
412 HEPATOCELLULAR INJURY 8 0.0006
413 HEPATIC FUNCTION ABNORMAL 21 0.0006
414 INTRA-ABDOMINAL FLUID COLLECTION 1 0.0006
415 LIVER TRANSPLANT REJECTION 1 0.0006
416 BLOOD HIV RNA INCREASED 1 0.0006
417 PNEUMONIA BACTERIAL 5 0.0005
418 DRUG LEVEL INCREASED 9 0.0005
419 PARADOXICAL DRUG REACTION 2 0.0005
420 RESPIRATORY DISTRESS 15 0.0005
421 GRANULOCYTE COUNT DECREASED 1 0.0005
422 LEUKOENCEPHALOPATHY 2 0.0005
423 BLADDER SPASM 1 0.0005
424 ORAL CANDIDIASIS 7 0.0005
425 SKIN TOXICITY 3 0.0005
426 INTERVERTEBRAL DISCITIS 1 0.0005
427 CATHETER SITE INFECTION 2 0.0005
428 BLOOD BICARBONATE DECREASED 1 0.0005
429 LYMPHADENOPATHY MEDIASTINAL 1 0.0005
430 SHOCK 12 0.0005
431 DEVICE RELATED INFECTION 8 0.0005
432 ENTEROCOLITIS 3 0.0005
433 HEPATIC MASS 1 0.0005
434 VIRAL LOAD INCREASED 2 0.0005
435 AZOTAEMIA 2 0.0005
436 TRANSPLANT REJECTION 4 0.0005
437 HEPATIC FAILURE 15 0.0005
438 HYPOPHYSITIS 1 0.0005
439 FOETAL GROWTH RESTRICTION 3 0.0005
440 SHOCK HAEMORRHAGIC 4 0.0005
441 ARTHRITIS BACTERIAL 2 0.0005
442 LARYNGEAL OEDEMA 3 0.0005
443 MYELODYSPLASTIC SYNDROME 7 0.0005
444 CHOLANGITIS 3 0.0005
445 OLIGURIA 3 0.0005
446 BLOOD ALKALINE PHOSPHATASE INCREASED 12 0.0005
447 EPSTEIN-BARR VIRUS INFECTION 3 0.0005
448 LIVEDO RETICULARIS 1 0.0005
449 PULSELESS ELECTRICAL ACTIVITY 2 0.0005
450 ESCHERICHIA URINARY TRACT INFECTION 2 0.0005
451 CD4 LYMPHOCYTES DECREASED 1 0.0005
452 TENSION HEADACHE 2 0.0005
453 EXOPHTHALMOS 1 0.0005
454 LYMPHOCYTOSIS 1 0.0005
455 HERPES SIMPLEX 3 0.0005
456 HEPATITIS ACUTE 3 0.0005
457 OCULAR ICTERUS 2 0.0005
458 CERVICAL DYSPLASIA 1 0.0005
459 ELECTROCARDIOGRAM ST SEGMENT DEPRESSION 1 0.0005
460 DIFFUSE LARGE B-CELL LYMPHOMA RECURRENT 1 0.0005
461 DISEASE COMPLICATION 2 0.0004
462 DRUG LEVEL ABOVE THERAPEUTIC 2 0.0004
463 RESPIRATORY DISORDER 13 0.0004
464 EYELID DISORDER 1 0.0004
465 HAEMOLYTIC URAEMIC SYNDROME 1 0.0004
466 IMPLANT SITE INFECTION 1 0.0004
467 HEPATIC ENCEPHALOPATHY 4 0.0004
468 OFF LABEL USE 375 0.0004
469 HYPERKALAEMIA 15 0.0004
470 DISSEMINATED INTRAVASCULAR COAGULATION 6 0.0004
471 LEUKAEMIA 4 0.0004
472 INGROWING NAIL 1 0.0004
473 BRONCHOSPASM 6 0.0004
474 MUCOSAL INFLAMMATION 11 0.0004
475 LACUNAR INFARCTION 1 0.0004
476 SUBCUTANEOUS ABSCESS 2 0.0004
477 MYELOSUPPRESSION 15 0.0004
478 DIABETES INSIPIDUS 1 0.0004
479 THROMBOTIC MICROANGIOPATHY 4 0.0004
480 CYTOPENIA 5 0.0004
481 HYPOPHOSPHATAEMIA 3 0.0004
482 GENERALISED OEDEMA 5 0.0004
483 INFLAMMATORY MARKER INCREASED 2 0.0004
484 PULMONARY MASS 6 0.0004
485 NEUROTOXICITY 7 0.0004
486 PNEUMOCYSTIS JIROVECII PNEUMONIA 4 0.0004
487 DERMATOMYOSITIS 1 0.0004
488 HEPATITIS 10 0.0004
489 ENDOCARDITIS 2 0.0004
490 DISSEMINATED TUBERCULOSIS 1 0.0004
491 BLOOD CHLORIDE DECREASED 1 0.0004
492 OSTEOMYELITIS 7 0.0004
493 ACTINIC KERATOSIS 1 0.0004
494 SERUM FERRITIN INCREASED 2 0.0004
495 CLOSTRIDIUM DIFFICILE COLITIS 4 0.0004
496 RENAL FAILURE 50 0.0004
497 BLOOD POTASSIUM ABNORMAL 1 0.0004
498 BLOOD DISORDER 3 0.0004
499 ASCITES 11 0.0004
500 HYPERLACTACIDAEMIA 1 0.0004
501 HYDROCEPHALUS 2 0.0004
502 ENCEPHALOPATHY 9 0.0004
503 ESCHERICHIA INFECTION 3 0.0004
504 CHOLESTASIS 7 0.0004
505 ACUTE GRAFT VERSUS HOST DISEASE IN SKIN 1 0.0004
506 HEMIPLEGIA 3 0.0004
507 CHOLECYSTITIS INFECTIVE 1 0.0004
508 RASH MACULO-PAPULAR 8 0.0004
509 CHOLECYSTITIS ACUTE 2 0.0004
510 FACIAL PARALYSIS 3 0.0004
511 ANAPHYLACTIC SHOCK 9 0.0003
512 ANURIA 3 0.0003
513 CARDIOGENIC SHOCK 5 0.0003
514 HERPES VIRUS INFECTION 2 0.0003
515 ADENOVIRUS INFECTION 1 0.0003
516 HAEMOTHORAX 1 0.0003
517 SPLENOMEGALY 4 0.0003
518 PERITONITIS 7 0.0003
519 HEPATITIS FULMINANT 1 0.0003
520 BACTERAEMIA 4 0.0003
521 ATYPICAL PNEUMONIA 1 0.0003
522 METABOLIC ENCEPHALOPATHY 1 0.0003
523 MIXED LIVER INJURY 1 0.0003
524 HYPERCAPNIA 1 0.0003
525 HIV INFECTION 1 0.0003
526 OPTIC NEURITIS 3 0.0003
527 KERATITIS 1 0.0003
528 CEREBRAL INFARCTION 8 0.0003
529 MASTICATION DISORDER 1 0.0003
530 DYSAESTHESIA 1 0.0003
531 RENAL DISORDER 15 0.0003
532 BLOOD CREATININE DECREASED 1 0.0003
533 GAMMA-GLUTAMYLTRANSFERASE INCREASED 7 0.0003
534 STEVENS-JOHNSON SYNDROME 7 0.0003
535 HEPATOTOXICITY 7 0.0003
536 POSTERIOR REVERSIBLE ENCEPHALOPATHY SYNDROME 3 0.0003
537 SEPSIS 35 0.0003
538 LIVER ABSCESS 1 0.0003
539 ELECTROCARDIOGRAM QT PROLONGED 11 0.0003
540 DEAFNESS NEUROSENSORY 1 0.0003
541 RENAL INJURY 9 0.0003
542 TOXIC SKIN ERUPTION 3 0.0003
543 BLOOD BILIRUBIN INCREASED 8 0.0003
544 HEMIPARESIS 5 0.0003
545 HEPATIC CYST 1 0.0003
546 DIABETIC RETINOPATHY 1 0.0003
547 CIRCULATORY COLLAPSE 5 0.0003
548 NEUTROPHIL COUNT INCREASED 3 0.0003
549 ACUTE HEPATIC FAILURE 4 0.0003
550 BRONCHOPNEUMONIA 1 0.0003
551 AUTOIMMUNE HAEMOLYTIC ANAEMIA 1 0.0003
552 ONYCHOCLASIS 2 0.0003
553 MULTI-ORGAN FAILURE 5 0.0003
554 THERAPY NON-RESPONDER 13 0.0003
555 LARGE INTESTINE PERFORATION 2 0.0003
556 PETECHIAE 3 0.0003
557 JAUNDICE CHOLESTATIC 1 0.0003
558 BONE EROSION 1 0.0003
559 FACIAL PARESIS 1 0.0003
560 APPENDICECTOMY 1 0.0003
561 LEUKOPENIA 14 0.0003
562 DRUG ADMINISTERED TO PATIENT OF INAPPROPRIATE AGE 2 0.0003
563 DERMATITIS BULLOUS 2 0.0003
564 RASH PUSTULAR 2 0.0003
565 STAPHYLOCOCCAL INFECTION 9 0.0003
566 AMYLASE INCREASED 1 0.0003
567 LIVER DISORDER 12 0.0003
568 OBSTRUCTIVE AIRWAYS DISORDER 3 0.0003
569 BACTERIAL INFECTION 5 0.0003
570 INTESTINAL PERFORATION 3 0.0003
571 TUBULOINTERSTITIAL NEPHRITIS 5 0.0003
572 MITRAL VALVE INCOMPETENCE 3 0.0003
573 ACIDOSIS 2 0.0003
574 ACUTE RESPIRATORY FAILURE 5 0.0003
575 THROMBOCYTOPENIA 29 0.0003
576 NEUTROPENIA 35 0.0003
577 HYPOALBUMINAEMIA 2 0.0003
578 HYPOXIA 9 0.0003
579 SKIN LESION 7 0.0003
580 CYANOSIS 4 0.0003
581 COVID-19 PNEUMONIA 3 0.0003
582 CHOLECYSTITIS 3 0.0003
583 TRICUSPID VALVE INCOMPETENCE 2 0.0003
584 LOW BIRTH WEIGHT BABY 2 0.0003
585 HAEMOPTYSIS 7 0.0003
586 CEREBRAL ATROPHY 1 0.0003
587 CREATININE RENAL CLEARANCE DECREASED 1 0.0002
588 ARTERIOSPASM CORONARY 1 0.0002
589 INTRACRANIAL ANEURYSM 1 0.0002
590 CYSTITIS HAEMORRHAGIC 1 0.0002
591 LACTIC ACIDOSIS 8 0.0002
592 DISEASE PROGRESSION 29 0.0002
593 ASPHYXIA 2 0.0002
594 EXTRAVASATION 1 0.0002
595 VENTRICULAR TACHYCARDIA 4 0.0002
596 GENERALISED TONIC-CLONIC SEIZURE 4 0.0002
597 GASTROINTESTINAL PERFORATION 1 0.0002
598 PULMONARY HYPERTENSION 5 0.0002
599 CONGESTIVE CARDIOMYOPATHY 1 0.0002
600 PYREXIA 83 0.0002
601 BLOOD UREA INCREASED 4 0.0002
602 HYPERPYREXIA 1 0.0002
603 LIP OEDEMA 1 0.0002
604 INCORRECT DRUG ADMINISTRATION RATE 1 0.0002
605 DRUG REACTION WITH EOSINOPHILIA AND SYSTEMIC SYMPTOMS 6 0.0002
606 LIVER FUNCTION TEST INCREASED 5 0.0002
607 HEPATIC LESION 1 0.0002
608 ALTERED STATE OF CONSCIOUSNESS 5 0.0002
609 PLEURAL EFFUSION 14 0.0002
610 NODULE 3 0.0002
611 RESPIRATORY SYNCYTIAL VIRUS INFECTION 2 0.0002
612 URINE OUTPUT DECREASED 2 0.0002
613 IMMUNE SYSTEM DISORDER 3 0.0002
614 TUMOUR LYSIS SYNDROME 2 0.0002
615 DRUG INTERACTION 36 0.0002
616 LYMPHOCYTE COUNT DECREASED 4 0.0002
617 ABDOMINAL ABSCESS 1 0.0002
618 HAEMOLYTIC ANAEMIA 2 0.0002
619 DRUG-INDUCED LIVER INJURY 7 0.0002
620 MENINGITIS ASEPTIC 1 0.0002
621 UVEITIS 3 0.0002
622 CENTRAL NERVOUS SYSTEM LESION 3 0.0002
623 CARDIAC ARREST 18 0.0002
624 ISCHAEMIA 1 0.0002
625 UROSEPSIS 2 0.0002
626 ARTHRITIS INFECTIVE 1 0.0002
627 AGRANULOCYTOSIS 4 0.0002
628 HYPONATRAEMIA 12 0.0002
629 SQUAMOUS CELL CARCINOMA 2 0.0002
630 LYMPHOPENIA 3 0.0002
631 CHRONIC LYMPHOCYTIC LEUKAEMIA 1 0.0002
632 SUBDURAL HAEMATOMA 3 0.0002
633 HYPOVOLAEMIC SHOCK 1 0.0002
634 GASTROINTESTINAL TOXICITY 1 0.0002
635 ATELECTASIS 2 0.0002
636 INCORRECT DOSAGE ADMINISTERED 1 0.0002
637 PHARYNGEAL SWELLING 2 0.0002
638 ABDOMINAL TENDERNESS 1 0.0002
639 HYPERNATRAEMIA 1 0.0002
640 HYPOTONIA 2 0.0002
641 ANAPHYLACTIC REACTION 11 0.0002
642 HYPOTHERMIA 2 0.0002
643 OXYGEN SATURATION DECREASED 11 0.0002
644 CACHEXIA 1 0.0002
645 PRODUCT USE IN UNAPPROVED INDICATION 48 0.0002
646 LUNG INFECTION 3 0.0002
647 HYPERBILIRUBINAEMIA 2 0.0002
648 FAILURE TO THRIVE 1 0.0002
649 VENTRICULAR EXTRASYSTOLES 2 0.0002
650 MALABSORPTION 1 0.0002
651 APLASTIC ANAEMIA 1 0.0002
652 DEAFNESS 5 0.0002
653 ANAL FISSURE 1 0.0002
654 INTESTINAL ISCHAEMIA 1 0.0002
655 DEAFNESS UNILATERAL 1 0.0002
656 MENTAL STATUS CHANGES 5 0.0002
657 ALANINE AMINOTRANSFERASE INCREASED 11 0.0002
658 MACULAR OEDEMA 1 0.0002
659 ACUTE PULMONARY OEDEMA 1 0.0002
660 DEPRESSED LEVEL OF CONSCIOUSNESS 7 0.0002
661 HEPATIC ENZYME INCREASED 12 0.0002
662 GENERALISED ERYTHEMA 1 0.0002
663 MYOCARDITIS 2 0.0002
664 PERICARDIAL EFFUSION 4 0.0002
665 DELIRIUM 6 0.0002
666 METABOLIC DISORDER 1 0.0002
667 BLINDNESS 7 0.0002
668 HYPERTRIGLYCERIDAEMIA 1 0.0002
669 PRODUCT USE ISSUE 32 0.0002
670 IMMUNE EFFECTOR CELL-ASSOCIATED NEUROTOXICITY SYNDROME 1 0.0002
671 TACHYCARDIA 15 0.0002
672 ISCHAEMIC STROKE 3 0.0002
673 RASH ERYTHEMATOUS 8 0.0002
674 INFUSION RELATED REACTION 11 0.0002
675 HEPATITIS B 1 0.0002
676 RENAL FAILURE ACUTE 7 0.0002
677 C-REACTIVE PROTEIN INCREASED 6 0.0002
678 HYPERGLYCAEMIA 6 0.0002
679 ANAEMIA 31 0.0002
680 CONCOMITANT DISEASE AGGRAVATED 1 0.0002
681 INFUSION SITE EXTRAVASATION 1 0.0002
682 BLISTER 9 0.0002
683 DYSARTHRIA 6 0.0002
684 BRAIN OEDEMA 2 0.0002
685 HEPATIC CYTOLYSIS 2 0.0002
686 METABOLIC ACIDOSIS 5 0.0002
687 ENTERITIS 1 0.0002
688 CONDITION AGGRAVATED 47 0.0002
689 CHILLS 18 0.0002
690 PLATELET COUNT INCREASED 2 0.0002
691 HYPOGAMMAGLOBULINAEMIA 1 0.0002
692 PANCREATITIS 8 0.0002
693 ARTERIOSCLEROSIS CORONARY ARTERY 1 0.0002
694 CARDIAC FAILURE ACUTE 1 0.0001
695 CARDIAC FAILURE 12 0.0001
696 LEFT VENTRICULAR DYSFUNCTION 1 0.0001
697 OEDEMA 8 0.0001
698 RESPIRATORY ARREST 4 0.0001
699 INFECTION 21 0.0001
700 JOINT EFFUSION 1 0.0001
701 INTERSTITIAL LUNG DISEASE 7 0.0001
702 HYPERTRANSAMINASAEMIA 1 0.0001
703 BLINDNESS UNILATERAL 2 0.0001
704 LYMPHADENOPATHY 5 0.0001
705 GENERAL PHYSICAL HEALTH DETERIORATION 16 0.0001
706 INTENTIONAL UNDERDOSE 1 0.0001
707 BLOOD PRESSURE DIASTOLIC DECREASED 1 0.0001
708 LOWER GASTROINTESTINAL HAEMORRHAGE 1 0.0001
709 CEREBRAL DISORDER 1 0.0001
710 HYDRONEPHROSIS 1 0.0001
711 ASPARTATE AMINOTRANSFERASE INCREASED 7 0.0001
712 HAEMODYNAMIC INSTABILITY 1 0.0001
713 BOWEL MOVEMENT IRREGULARITY 1 0.0001
714 LIPASE INCREASED 1 0.0001
715 DEATH 112 0.0001
716 PNEUMONIA 42 0.0001
717 HAEMOLYSIS 1 0.0001
718 ATRIOVENTRICULAR BLOCK 1 0.0001
719 LOW DENSITY LIPOPROTEIN INCREASED 1 0.0001
720 ACUTE GENERALISED EXANTHEMATOUS PUSTULOSIS 1 0.0001
721 APNOEA 1 0.0001
722 THERAPY PARTIAL RESPONDER 2 0.0001
723 ARTERIAL OCCLUSIVE DISEASE 1 0.0001
724 DISEASE RECURRENCE 6 0.0001
725 BLOOD ALBUMIN DECREASED 1 0.0001
726 MEDICATION ERROR 7 0.0001
727 HALLUCINATION, AUDITORY 2 0.0001
728 PREMATURE DELIVERY 2 0.0001
729 ATRIAL FLUTTER 1 0.0001
730 HYPOTENSION 25 0.0001
731 NEURALGIA 3 0.0001
732 BLOOD POTASSIUM INCREASED 2 0.0001
733 DECUBITUS ULCER 1 0.0001
734 LIVER INJURY 3 0.0001
735 ACUTE CORONARY SYNDROME 1 0.0001
736 VISUAL ACUITY REDUCED 4 0.0001
737 PNEUMONIA ASPIRATION 3 0.0001
738 CELLULITIS 6 0.0001
739 UPPER GASTROINTESTINAL HAEMORRHAGE 2 0.0001
740 CARDIOVASCULAR DISORDER 3 0.0001
741 SKIN ULCER 3 0.0001
742 THERAPEUTIC RESPONSE DECREASED 7 0.0001
743 STOMATITIS 7 0.0001
744 EOSINOPHILIA 2 0.0001
745 LUNG INFILTRATION 1 0.0001
746 BLOOD TRIGLYCERIDES INCREASED 2 0.0001
747 LABELLED DRUG-DRUG INTERACTION MEDICATION ERROR 1 0.0001
748 EXPOSURE DURING PREGNANCY 7 0.0001
749 CARDIOTOXICITY 1 0.0001
750 FACIAL PAIN 1 0.0001
751 PULMONARY OEDEMA 5 0.0001
752 CONJUNCTIVITIS 2 0.0001
753 THINKING ABNORMAL 2 0.0001
754 ERYTHEMA MULTIFORME 1 0.0001
755 APPENDICITIS 1 0.0001
756 FLANK PAIN 1 0.0001
757 PHOTOPHOBIA 2 0.0001
758 HYPOCALCAEMIA 2 0.0001
759 HAEMATOTOXICITY 1 0.0001
760 GASTRIC ULCER 2 0.0001
761 PROTEINURIA 2 0.0001
762 SEIZURE 12 0.0001
763 PRESCRIBED OVERDOSE 2 0.0001
764 ORAL HERPES 2 0.0001
765 DRUG EFFECTIVE FOR UNAPPROVED INDICATION 3 0.0001
766 VISION BLURRED 14 0.0001
767 HEPATOMEGALY 1 0.0001
768 MATERNAL EXPOSURE DURING PREGNANCY 9 0.0001
769 DISORIENTATION 4 0.0001
770 INABILITY TO AFFORD MEDICATION 1 0.0001
771 BRAIN INJURY 1 0.0001
772 PREMATURE BABY 3 0.0001
773 EYELID PTOSIS 1 0.0001
774 BODY TEMPERATURE INCREASED 2 0.0001
775 INAPPROPRIATE ANTIDIURETIC HORMONE SECRETION 1 0.0001
776 NERVOUS SYSTEM DISORDER 3 0.0001
777 RHABDOMYOLYSIS 4 0.0001
778 DERMATITIS 2 0.0001
779 MOUTH ULCERATION 2 0.0001
780 PRURITUS GENERALISED 2 0.0001
781 CLOSTRIDIUM DIFFICILE INFECTION 2 0.0001
782 TREATMENT NONCOMPLIANCE 5 0.0001
783 MALNUTRITION 1 0.0001
784 FISTULA 1 0.0001
785 TOXICITY TO VARIOUS AGENTS 15 0.0001
786 EYE INFECTION 1 0.0001
787 HAEMATURIA 3 0.0001
788 INTERNAL HAEMORRHAGE 1 0.0001
789 NEPHROLITHIASIS 4 0.0001
790 CARDIAC FAILURE CONGESTIVE 7 0.0001
791 COGNITIVE DISORDER 4 0.0001
792 VOMITING 40 0.0001
793 PLATELET COUNT DECREASED 9 0.0001
794 INCORRECT ROUTE OF DRUG ADMINISTRATION 3 0.0001
795 MENTAL IMPAIRMENT 2 0.0001
796 ADRENAL INSUFFICIENCY 1 0.0001
797 LUNG DISORDER 4 0.0001
798 HYPERCALCAEMIA 1 0.0001
799 HALLUCINATION 6 0.0001
800 GASTRIC CANCER 2 0.0001
801 INTRAOCULAR PRESSURE INCREASED 1 0.0001
802 HYPOPHAGIA 2 0.0001
803 WHITE BLOOD CELL COUNT INCREASED 3 0.0001
804 CHEST DISCOMFORT 8 0.0001
805 METASTASES TO CENTRAL NERVOUS SYSTEM 1 0.0001
806 INFLAMMATION 4 0.0001
807 UNRESPONSIVE TO STIMULI 2 0.0001
808 RASH GENERALISED 2 0.0001
809 HAEMATOMA 2 0.0001
810 SWELLING FACE 5 0.0001
811 RESPIRATORY TRACT INFECTION 2 0.0001
812 ANKYLOSING SPONDYLITIS 1 0.0001
813 CHEST PAIN 14 0.0001
814 BRADYCARDIA 4 0.0001
815 THROAT TIGHTNESS 2 0.0001
816 PALLOR 2 0.0001
817 MEMORY IMPAIRMENT 10 0.0001
818 DIVERTICULITIS 2 0.0001
819 MASS 1 0.0001
820 DIALYSIS 1 0.0001
821 THERAPEUTIC PRODUCT EFFECT INCOMPLETE 5 0.0001
822 BLOOD CREATINE PHOSPHOKINASE INCREASED 2 0.0001
823 HYPERTHYROIDISM 1 0.0001
824 HYPOKINESIA 1 0.0001
825 APATHY 1 0.0001
826 GASTROENTERITIS 1 0.0001
827 CARDIOMYOPATHY 1 0.0001
828 HAEMORRHAGE INTRACRANIAL 1 0.0001
829 CHRONIC KIDNEY DISEASE 5 0.0001
830 EPILEPSY 2 0.0001
831 FEELING HOT 4 0.0001
832 LYMPHOMA 1 0.0001
833 DELUSION 1 0.0001
834 EJECTION FRACTION DECREASED 1 0.0001
835 BLOOD LACTATE DEHYDROGENASE INCREASED 1 0.0001
836 PRODUCTIVE COUGH 3 0.0001
837 CYSTITIS 2 0.0001
838 ABSCESS 1 0.0001
839 CONFUSIONAL STATE 10 0.0001
840 DYSPNOEA 35 0.0001
841 CHOLELITHIASIS 2 0.0001
842 VIRAL INFECTION 2 0.0001
843 COAGULOPATHY 1 0.0001
844 SKIN DISORDER 2 0.0001
845 FACE OEDEMA 1 0.0001
846 SINUSITIS 6 0.0001
847 THERAPY CESSATION 3 0.0001
848 ECZEMA 3 0.0001
849 INTENTIONAL PRODUCT USE ISSUE 5 0.0001
850 VISUAL IMPAIRMENT 7 0.0001
851 CEREBRAL HAEMORRHAGE 2 0.0001
852 WHITE BLOOD CELL COUNT DECREASED 6 0.0001
853 LEUKOCYTOSIS 1 0.0001
854 DRUG EFFECT INCOMPLETE 2 0.0001
855 CONSTIPATION 12 0.0001
856 UNDERDOSE 4 0.0001
857 HYPERSENSITIVITY 10 0.0001
858 HEPATIC CIRRHOSIS 1 0.0001
859 DYSPNOEA EXERTIONAL 2 0.0001
860 BLOOD SODIUM DECREASED 1 0.0001
861 RASH 23 0.0001
862 COLITIS 2 0.0001
863 BLOOD URINE PRESENT 1 0.0001
864 NEUROPATHY PERIPHERAL 5 0.0001
865 HERPES ZOSTER 3 0.0001
866 GLAUCOMA 1 0.0001
867 ABDOMINAL PAIN 12 0.0001
868 WHEEZING 3 0.0001
869 HAEMATOCRIT DECREASED 1 0.0001
870 CATARACT 3 0.0001
871 ABORTION SPONTANEOUS 2 0.0000
872 CYTOKINE RELEASE SYNDROME 1 0.0000
873 ILL-DEFINED DISORDER 3 0.0000
874 FEEDING DISORDER 1 0.0000
875 FOETAL EXPOSURE DURING PREGNANCY 4 0.0000
876 NEUTROPHIL COUNT DECREASED 2 0.0000
877 GASTROINTESTINAL HAEMORRHAGE 4 0.0000
878 CARDIO-RESPIRATORY ARREST 2 0.0000
879 HYPOACUSIS 2 0.0000
880 INCORRECT PRODUCT ADMINISTRATION DURATION 1 0.0000
881 AMNESIA 3 0.0000
882 MELAENA 1 0.0000
883 ANGIOEDEMA 2 0.0000
884 TINNITUS 2 0.0000
885 UPPER RESPIRATORY TRACT INFECTION 2 0.0000
886 OROPHARYNGEAL PAIN 4 0.0000
887 COUGH 12 0.0000
888 ARRHYTHMIA 2 0.0000
889 INAPPROPRIATE SCHEDULE OF DRUG ADMINISTRATION 3 0.0000
890 COMA 2 0.0000
891 AGITATION 3 0.0000
892 DYSGEUSIA 3 0.0000
893 SYNCOPE 4 0.0000
894 ABDOMINAL PAIN LOWER 1 0.0000
895 HAEMATEMESIS 1 0.0000
896 DIABETES MELLITUS 3 0.0000
897 FLUSHING 4 0.0000
898 FLUID RETENTION 2 0.0000
899 HAEMOGLOBIN DECREASED 4 0.0000
900 ERYTHEMA 8 0.0000
901 DIPLOPIA 1 0.0000
902 THROMBOSIS 3 0.0000
903 JAUNDICE 1 0.0000
904 DISTURBANCE IN ATTENTION 2 0.0000
905 NAUSEA 29 0.0000
906 ABNORMAL DREAMS 1 0.0000
907 URTICARIA 6 0.0000
908 EYE PAIN 2 0.0000
909 ANGINA PECTORIS 1 0.0000
910 DYSPHONIA 2 0.0000
911 BONE PAIN 2 0.0000
912 ACUTE MYOCARDIAL INFARCTION 1 0.0000
913 IRRITABILITY 2 0.0000
914 APHASIA 1 0.0000
915 HYPERTENSION 7 0.0000
916 VERTIGO 2 0.0000
917 DRUG ADMINISTRATION ERROR 1 0.0000
918 DIARRHOEA 21 0.0000
919 FEMUR FRACTURE 1 0.0000
920 CARDIAC DISORDER 3 0.0000
921 HEADACHE 20 0.0000
922 INTENTIONAL OVERDOSE 2 0.0000
923 DRUG INTOLERANCE 3 0.0000
924 HYPERHIDROSIS 4 0.0000
925 RHINORRHOEA 2 0.0000
926 INCORRECT DOSE ADMINISTERED 7 0.0000
927 IMPAIRED HEALING 1 0.0000
928 DECREASED APPETITE 7 0.0000
929 BLOOD PRESSURE DECREASED 2 0.0000
930 LIP SWELLING 1 0.0000
931 GAIT INABILITY 1 0.0000
932 MYALGIA 5 0.0000
933 ABDOMINAL DISTENSION 3 0.0000
934 HAEMORRHAGE 3 0.0000
935 ACCIDENTAL OVERDOSE 1 0.0000
936 DYSURIA 1 0.0000
937 BLOOD GLUCOSE INCREASED 5 0.0000
938 ALOPECIA 5 0.0000
939 OEDEMA PERIPHERAL 3 0.0000
940 DYSKINESIA 1 0.0000
941 LUNG NEOPLASM MALIGNANT 1 0.0000
942 URINARY TRACT INFECTION 4 0.0000
943 BALANCE DISORDER 2 0.0000
944 COVID-19 4 0.0000
945 ADVERSE DRUG REACTION 2 0.0000
946 LOWER RESPIRATORY TRACT INFECTION 1 0.0000
947 WEIGHT DECREASED 6 0.0000
948 BLOOD CHOLESTEROL INCREASED 1 0.0000
949 DYSPHAGIA 2 0.0000
950 PULMONARY EMBOLISM 2 0.0000
951 PRURITUS 8 0.0000
952 CONTUSION 2 0.0000
953 HYPOGLYCAEMIA 1 0.0000
954 MALAISE 9 0.0000
955 HEART RATE INCREASED 2 0.0000
956 HYPOAESTHESIA 3 0.0000
957 AGGRESSION 1 0.0000
958 MALIGNANT NEOPLASM PROGRESSION 2 0.0000
959 PAIN 11 0.0000
960 FLATULENCE 1 0.0000
961 LETHARGY 1 0.0000
962 PALPITATIONS 2 0.0000
963 NASOPHARYNGITIS 3 0.0000
964 LOSS OF CONSCIOUSNESS 2 0.0000
965 DEEP VEIN THROMBOSIS 1 0.0000
966 INSOMNIA 4 0.0000
967 PRODUCT QUALITY ISSUE 2 0.0000
968 INJECTION SITE REACTION 1 0.0000
969 FATIGUE 11 0.0000
970 OVERDOSE 3 0.0000
971 EPISTAXIS 1 0.0000
972 ASTHENIA 5 0.0000
973 PERIPHERAL SWELLING 2 0.0000
974 BACK PAIN 3 0.0000
975 PARAESTHESIA 2 0.0000
976 INFLUENZA LIKE ILLNESS 1 0.0000
977 TREMOR 2 0.0000
978 ARTHRALGIA 5 0.0000
979 FALL 4 0.0000
980 CEREBROVASCULAR ACCIDENT 2 0.0000
981 GASTROINTESTINAL DISORDER 1 0.0000
982 INAPPROPRIATE SCHEDULE OF PRODUCT ADMINISTRATION 2 0.0000
983 ADVERSE EVENT 1 0.0000
984 ATRIAL FIBRILLATION 1 0.0000
985 PAIN IN EXTREMITY 3 0.0000
986 WRONG TECHNIQUE IN PRODUCT USAGE PROCESS 2 0.0000
987 WEIGHT INCREASED 2 0.0000
988 FEELING ABNORMAL 2 0.0000
989 DEHYDRATION 1 0.0000
990 DRY SKIN 1 0.0000
991 HOSPITALISATION 1 0.0000
992 DIZZINESS 3 0.0000
993 GAIT DISTURBANCE 1 0.0000
994 ABDOMINAL PAIN UPPER 1 0.0000
995 ANXIETY 1 0.0000